Mallett, Veronica <br/><br/>
Solifenacin treatment for overactive bladder in black patients: patient-reported symptom bother and health-related quality of life outcomes.  [electronic resource] 

 -  Current medical research and opinion  Apr 2007 
 - 821-31 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/030079907x178847  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Black or African American<br/>Aged<br/>Aged, 80 and over<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Muscarinic Antagonists--adverse effects<br/>Quality of Life<br/>Quinuclidines--adverse effects<br/>Solifenacin Succinate<br/>Tetrahydroisoquinolines--adverse effects<br/>Treatment Outcome<br/>Urinary Bladder, Overactive--drug therapy